Methyl iodide → HCID 90412921, compound
Reaction equation
[F:1][C:2]1[C:3]([C:28]2[N:33]=[CH:32][CH:31]=[CH:30][N:29]=2)=[C:4]([C:8]([N:10]2[C@@H:14]3[CH2:15][CH2:16][C@H:11]2[C@H:12]([NH:17][C:18]2[CH:23]=[N:22][C:21]([C:24]([F:27])([F:26])[F:25])=[CH:20][N:19]=2)[CH2:13]3)=[O:9])[CH:5]=[CH:6][CH:7]=1.[CH3:34]C(C)([O-])C.[Na+].IC>CN(C=O)C.CCOC(C)=O.O>[F:1][C:2]1[C:3]([C:28]2[N:29]=[CH:30][CH:31]=[CH:32][N:33]=2)=[C:4]([C:8]([N:10]2[C@@H:14]3[CH2:15][CH2:16][C@H:11]2[C@H:12]([N:17]([CH3:34])[C:18]2[CH:23]=[N:22][C:21]([C:24]([F:25])([F:27])[F:26])=[CH:20][N:19]=2)[CH2:13]3)=[O:9])[CH:5]=[CH:6][CH:7]=1Participants
Procedure
The title compound of Example 238 (63 mg, 0.14 mmol) was dissolved in DMF (1.4 mL) and then sodium tert-butoxide (15 mg, 0.15 mmol) followed by iodomethane (9 μL, 0.14 mmol) were added. After 15 h at room temperature the reaction mixture was diluted with EtOAc and water was added. The aqueous phase was extracted twice with EtOAc and the combined organic phases were dried over MgSO4, filtered and evaporated. Purification was performed using Agilent prep method X to give the title compound (40 mg, 62%). MS (ESI) mass calcd. for: C23H20F4N6O, 472.2. m/z found 473.2 [M+H]+. 1H NMR (500 MHz, Chloroform-d) 8.81 (d, J=4.9 Hz, 2H), 8.35 (s, 1H), 8.02 (s, 1H), 7.55-7.46 (m, 1H), 7.34-7.20 (m, 3H), 4.81-4.73 (m, 1H), 4.67 (d, J=4.3 Hz, 1H), 4.17-4.08 (m, 1H), 3.05 (s, 3H), 2.12 (dd, J=12.8, 8.3 Hz, 1H), 1.98-1.44 (m, 5H).
Workup
- additionwere added
- additionwas added
- extractionThe aqueous phase was extracted twice with EtOAc
- dry with materialthe combined organic phases were dried over MgSO4
- filtrationfiltered
- customevaporated
- customPurification
Sources & evidence
- ORD record
- ord-34b39a5df38c448fbb3f8f22aaedf9d3
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09062078B2
Reaction notes
Loading…